全文获取类型
收费全文 | 53378篇 |
免费 | 2745篇 |
国内免费 | 1261篇 |
专业分类
耳鼻咽喉 | 269篇 |
儿科学 | 1493篇 |
妇产科学 | 239篇 |
基础医学 | 2600篇 |
口腔科学 | 96篇 |
临床医学 | 8301篇 |
内科学 | 9705篇 |
皮肤病学 | 286篇 |
神经病学 | 2380篇 |
特种医学 | 1563篇 |
外科学 | 4634篇 |
综合类 | 10774篇 |
现状与发展 | 1篇 |
预防医学 | 4512篇 |
眼科学 | 247篇 |
药学 | 6423篇 |
50篇 | |
中国医学 | 2324篇 |
肿瘤学 | 1487篇 |
出版年
2024年 | 83篇 |
2023年 | 623篇 |
2022年 | 1555篇 |
2021年 | 2070篇 |
2020年 | 1836篇 |
2019年 | 1441篇 |
2018年 | 1493篇 |
2017年 | 1665篇 |
2016年 | 1939篇 |
2015年 | 1830篇 |
2014年 | 4439篇 |
2013年 | 4345篇 |
2012年 | 3869篇 |
2011年 | 3984篇 |
2010年 | 3113篇 |
2009年 | 2672篇 |
2008年 | 2650篇 |
2007年 | 2673篇 |
2006年 | 2376篇 |
2005年 | 1949篇 |
2004年 | 1563篇 |
2003年 | 1303篇 |
2002年 | 968篇 |
2001年 | 898篇 |
2000年 | 740篇 |
1999年 | 670篇 |
1998年 | 531篇 |
1997年 | 492篇 |
1996年 | 418篇 |
1995年 | 426篇 |
1994年 | 361篇 |
1993年 | 247篇 |
1992年 | 217篇 |
1991年 | 226篇 |
1990年 | 204篇 |
1989年 | 180篇 |
1988年 | 176篇 |
1987年 | 132篇 |
1986年 | 112篇 |
1985年 | 174篇 |
1984年 | 137篇 |
1983年 | 73篇 |
1982年 | 93篇 |
1981年 | 82篇 |
1980年 | 78篇 |
1979年 | 57篇 |
1978年 | 55篇 |
1977年 | 53篇 |
1976年 | 32篇 |
1975年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
目的探讨经皮冠状动脉介入(PCI)和静脉溶栓在急性心肌梗死患者中的应用价值。方法选择我院2013年1月至2014年9月收治的60例急性心肌梗死患者作为研究对象,随机分为实验组和对照组各30例。实验组患者采用PCI治疗,对照组患者采用静脉溶栓治疗,比较两组患者血管再通率、死亡发生率、ST段回落情况、住院时间、近远期不良事件发生率、左室舒张末径和左室射血分数变化情况。结果实验组血管再通率显著高于对照组,差异有统计学意义(P<0.05),而近期和远期不良事件发生率均低于对照组,近期不良事件发生率组间比较差异有统计学意义(P<0.05),而远期不良事件发生率比较差异无统计学意义(P>0.05)。实验组患者死亡发生率、ST段回落和住院时间均低于对照组,差异均有统计学意义(P<0.05)。实验组左室射血分数在术后1个月、3个月和6个月时均显著高于对照组,差异均有统计学意义(P<0.05)。结论急性心肌梗死患者应用PCI治疗可显著提高血管再通率、降低死亡和不良事件发生率,有效改善心功能。 相似文献
23.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
24.
25.
《Radiologic clinics of North America》2019,57(6):1083-1091
26.
27.
《Vaccine》2016,34(50):6316-6322
ObjectiveAir pollution, weather condition and influenza are known risk factors of acute coronary syndrome (ACS) among elderly people. The influenza vaccine (IV) has been shown to reduce major cardiovascular events. The purpose of this study was to compare resistance to air pollution and weather factors causing ACS between vaccinated and less-vaccinated elderly people.MethodsA case–crossover design was applied to 1835 elderly ACS patients who were obtained from the 1-million sample of Taiwan National Health Insurance Research Data with inclusion criteria: (1) the first diagnosis of ACS was in cold season and at age 68 or more, (2) had received the free IV program at least once during the period 3 years before the ACS. They were stratified into two groups: 707 had received flu vaccinations for all the 3 years and the remaining 1128 had not. The measurements of air pollutants, temperature, and humidity corresponding to each of the 3 days prior to the ACS diagnosis date were retrieved from the data banks of the Taiwan Environmental Protection Administration and Central Weather Bureau.FindingsIncreases in air pollution concentrations of CO, NO2, PM10 or PM2.5 and decreases in temperature significantly influenced the risk of ACS for the non-continuously vaccinated elderly population; however, less significant effects were observed for the continuously vaccinated population.ConclusionConsecutive influenza vaccination may potentially offer resistance against the detrimental effects of air pollution and changes in temperature in frail elderly adults with ACS. Future studies are needed to directly assess the interaction effect between the vaccination and environmental factors on ACS. 相似文献
28.
《Best Practice & Research: Clinical Haematology》2020,33(4):101220
Acute myeloid leukemia (AML) remains a therapeutically challenging malignancy with high rate of relapse and poor outcomes. There has been increased understanding of the molecular characteristics of AML and the various roles of the immune system in its pathogenesis, the result of which has led to the study and development of multiple immune-based approaches for this disease. In this review, we aim to provide an overview of the recent advancements made in antibody-based approaches to the treatment of AML including monoclonal antibodies, antibody-drug conjugates, and immune checkpoint inhibition. In addition, we provide insight and discuss the promise of these agents, some of which may soon enter the therapeutic armamentarium we currently employ against this lethal disease. 相似文献
29.
目的 观察SWIM技术治疗后循环大血管闭塞所致急性缺血性卒中的有效性及安全性。
方法 回顾性分析2017年2月-2018年11月于大连市中心医院采用SWIM技术治疗的后循环大血管闭
塞所致急性缺血性卒中患者的临床资料,评价该技术的疗效和安全性,并分析影响患者预后的因素。
观察指标为术后即刻成功再通(mTICI≥2b)、90 d良好预后(mRS评分≤2分),以及术后24 h任何颅内
出血、90 d全因死亡。
结果 共纳入35例患者,平均年龄66.1±12.1岁,男性26例(74.3%),基线NIHSS评分22(15~34)分。
术后即刻成功再通率为94.3%(33/35),90 d良好预后率为45.7%(16/35),24 h颅内出血率为17.1%
(6/35),90 d全因死亡率为37.1%(13/35)。单因素分析显示,基线NIHSS评分较低(P =0.001)、基
线后循环ASPECTS评分较高(P =0.016)、发病至到院时间较短(P =0.039)、发病至再通时间较短
(P =0.047)、血管成功再通率较高(P =0.036)以及饮酒比例较低(P =0.042)与良好预后相关。
结论 使用SWIM技术治疗后循环急性缺血性卒中相对安全、有效。 相似文献
30.